While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Investigators compared outcomes among patients with psoriasis undergoing apremilast treatment with genital involvement versus those without genital involvement.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

“Psoriasis is an inflammatory skin disorder ... “There are topical treatment options, oral treatments, and biologics,” Dr. Noor said. “With some of our newer advancements and research ...

Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...